Cargando…

Newborn bloodspot screening in the time of COVID-19

PURPOSE: A COVID-19 pandemic business continuity plan (BCP) was rapidly developed to protect the Victorian newborn screening (NBS) program. Here, we present the outcomes of our COVID-19 BCP and its impact on the Victorian NBS laboratory service. METHODS: Change management principles were used to dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greaves, Ronda F., Pitt, James, McGregor, Candice, Wall, Meaghan, Christodoulou, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804212/ https://www.ncbi.nlm.nih.gov/pubmed/33442021 http://dx.doi.org/10.1038/s41436-020-01086-6

Ejemplares similares

Processing Newborn Bloodspot Screening Results for CF
por: Barben, Jürg, et al.
Publicado: (2020)

Parents’ views on accepting, declining, and expanding newborn bloodspot screening
por: van der Pal, Sylvia M., et al.
Publicado: (2022)

Understanding Midwives’ Preferences for Providing Information About Newborn Bloodspot Screening
por: Wright, Stuart James, et al.
Publicado: (2018)

Parental Decision-Making and Acceptance of Newborn Bloodspot Screening: An Exploratory Study
por: Nicholls, Stuart G., et al.
Publicado: (2013)

Variability in the storage and use of newborn dried bloodspots in Canada: is it time for national standards?
por: Avard, Denise, et al.
Publicado: (2006)

The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review
por: Wright, Stuart J., et al.
Publicado: (2015)

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
por: Armstrong, Rachael E., et al.
Publicado: (2020)

Secondary research uses of residual newborn screening dried bloodspots: a scoping review
por: Rothwell, Erin, et al.
Publicado: (2018)

Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
por: Boychuk, Natalie A., et al.
Publicado: (2022)

Process evaluation of co-designed interventions to improve communication of positive newborn bloodspot screening results
por: Chudleigh, Jane, et al.
Publicado: (2021)

Co-designing Improved Communication of Newborn Bloodspot Screening Results to Parents: Mixed Methods Study
por: Chudleigh, Jane, et al.
Publicado: (2022)

The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020)

Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice
por: Lombardo, Silvia, et al.
Publicado: (2023)

Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
por: Nicholls, S G, et al.
Publicado: (2014)

Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency
por: Brown, Madalyn, et al.
Publicado: (2020)

Assessing a New Method for Measuring Fetal Exposure to Mercury: Newborn Bloodspots
por: Nelson, Jessica W., et al.
Publicado: (2016)

Qualitative exploration of health professionals’ experiences of communicating positive newborn bloodspot screening results for nine conditions in England
por: Chudleigh, Jane, et al.
Publicado: (2020)

Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study
por: Johnson, Faye, et al.
Publicado: (2019)

Parental Awareness, Knowledge, and Attitudes Regarding Current and Future Newborn Bloodspot Screening: The First Report from Thailand
por: Wilaiwongsathien, Kalyarat, et al.
Publicado: (2023)

Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective
por: van Dijk, Tessa, et al.
Publicado: (2021)

What Mothers Know about Newborn Bloodspot Screening and the Sources They Use to Acquire This Knowledge: A Pilot Study in Flanders
por: di Gangi, Caroline, et al.
Publicado: (2023)

Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7
por: Streetly, A, et al.
Publicado: (2009)

Influence of maternal socioeconomic deprivation and living environment on newborn bloodspot 25-hydroxyvitamin D levels
por: Högler, Wolfgang, et al.
Publicado: (2022)

Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province
por: Luo, Haiyan, et al.
Publicado: (2022)

Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?
por: Vears, Danya F, et al.
Publicado: (2023)

Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders
por: Jansen, Marleen E., et al.
Publicado: (2021)

Association between Several Persistent Organic Pollutants and Thyroid Hormone Levels in Cord Blood Serum and Bloodspot of the Newborn Infants of Korea
por: Kim, Sunmi, et al.
Publicado: (2015)

Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method
por: Bleyle, Lisa, et al.
Publicado: (2016)

Neonatal Lead (Pb) Exposure and DNA Methylation Profiles in Dried Bloodspots
por: Montrose, Luke, et al.
Publicado: (2020)

Methyl-CpG-Binding PCR of Bloodspots for Confirmation of Fragile X Syndrome in Males
por: Tzeng, Ching-Cherng, et al.
Publicado: (2009)

Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots
por: Kuwahata, Melissa, et al.
Publicado: (2010)

BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis
por: Bagger, Frederik Otzen, et al.
Publicado: (2016)

Neonatal Bloodspot DNA Methylation Patterns are Associated with Childhood Weight Status in the Healthy Families Project
por: Kochmanski, Joseph, et al.
Publicado: (2018)

Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study
por: Jansen, Marleen E., et al.
Publicado: (2019)

Urea Cycle Related Amino Acids Measured in Dried Bloodspots Enable Long-Term In Vivo Monitoring and Therapeutic Adjustment
por: Baruteau, Julien, et al.
Publicado: (2019)

Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow
por: Godler, David E., et al.
Publicado: (2022)

Global impact of COVID-19 on newborn screening programmes
por: Koracin, Vanesa, et al.
Publicado: (2022)

A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism
por: Wang, Wenjie, et al.
Publicado: (2019)

Critical Issues in the Management of Newborn Hearing Screening in the Time of COVID-19 in Umbria, Italy
por: Gambacorta, Valeria, et al.
Publicado: (2022)

BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles
por: Bagger, Frederik Otzen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iqoi7k8qrd9dm0lio1vc0j9m2d